Gender differences among persons with HIV admitted to a university reference center in São Paulo, Brazil;Diferenças de gênero ao acolhimento de pessoas vivendo com HIV em serviço universitário de referência de São Paulo, Brasil

Cadernos de Saude Publica

Volumn 23, Issue 11, 2007, Pages 2653-2662

  Braga, Patrícia Emilia ^a   Cardoso, Maria Regina Alves ^a   Segurado, Aluisio Cotrim ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Acquired immunodeficiency syndrome; Gender identity; Health services accessibility; HIV

Indexed keywords

EID: 36148949768     PISSN: 0102311X     EISSN: 16784464     Source Type: Journal    
DOI: 10.1590/s0102-311x2007001100013     Document Type: Review

References (40)

1. Joint United Nations Programme on HIV/AIDS. AIDS epidemic update. Geneva: Joint United Nations Programme on HIV/AIDS; 2005.
2. Pan American Health Organization. Women and HIV/AIDS: prevention and care strategies. Washington DC: Pan American Health Organization; 2000.
3. Joint United Nations Programme on HIV/AIDS. Report on the global AIDS epidemic. Geneva: Joint United Nations Programme on HIV/AIDS; 2004.
4. Parker R, Galvão J. Quebrando o silêncio: mulheres e AIDS no Brasil. Rio de Janeiro: Editora Relume-Dumará/Associação Brasileira Interdisciplinar de AIDS/Instituto de Medicina Social, Universidade do Estado do Rio de Janeiro; 1996.
5. Ministério da Saúde. Boletim Epidemiológico AIDS 2004; 17(1).
6. Heilborn ML. De que gênero estamos falando? Sexualidade, Gênero e Sociedade 1994; (2):1-8.
7. Scott J. Gênero: uma categoria útil de análise histórica. Educação e Realidade 1995; 20:71-99.
8. Rohlfs I, Borrel C, Fonseca MC. Género, desigualdades y salud pública: conocimientos y desconocimientos. Gac Sanit 2000; 14 Suppl 3:60-71.
9. Kalton G. Introduction to survey sampling. Beverly Hills: Sage Publications; 1983.
10. Dunne MT, Ruskin HJ, Mulcahy FM. Survival with AIDS in Ireland. AIDS 1997; 11:1281-90.
11. Armbruster C, Kriwanek S, Vorbach H. Gender-specific differences in the natural history, clinical features, and socioeconomic status of HIV-infected patients: experience of a treatment centre in Vienna. Wien Klin Wochenschr 2000; 17:754-60.
12. Mocroft A, Gill MJ, Davidson W, Phillips AN. Are there gender differences in starting protease inhibitors, HAART, and disease progression despite equal access to care? J Acquir Immune Defic Syndr 2000; 24:475-82.
13. Moore AL, Kirk O, Johnson AM, Katlama C, Blaxhult A, Dietrich M, et al. Virologic, immunologic, and clinical response to highly active antiretroviral therapy: the gender issue revisited. J Acquir Immune Defic Syndr 2003; 32:452-61.
14. Kenagy G, Linsk NL, Bruce D, Warnecke R, Gordon A, Wagaw F, et al. Service utilization, service barriers and gender among HIV-positive consumers in primary care. AIDS Patient Care STDS 2003; 17:235-44.
15. Nicastri E, Angeletti C, Palmisano L, Sarmati L, Chiesi A, Geraci A, et al. Gender differences in clinical progression of HIV-1-infected individuals during long-term highly active antiretroviral therapy. AIDS 2005; 19:577-83.
16. Loupa CV, Rodriguez B, McComsey G, Gripshover B, Salata RA, Valdez H, et al. Gender differences in human immunodeficiency virus (HIV) RNA and CD4 cell counts among new entrants to HIV care. Clin Microbiol Infect 2006; 12:389-91.
17. Joint United Nations Programme on HIV/AIDS. Situación de la epidemia de SIDA: 2004. Geneva: Organización Mundial de la Salud; 2004.
18. Türmen T. Gender and HIV/AIDS. Int J Gynaecol Obstet 2003; 82:411-8.
19. Joint United Nations Programme on HIV/AIDS. Gender and HIV/AIDS. Geneva: Joint United Nations Programme on HIV/AIDS; 2003.
20. Santoro-Lopes G, Harrison LH, Moulton LH, Lima LAA, Pinho AMF, Hofer C, et al. Gender and survival after AIDS in Rio de Janeiro, Brazil. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 19:403-7.
21. Moore AL, Sabin CA, Johnson MA, Phillips NA. Gender and clinical outcomes after starting highly active antiretroviral treatment: a cohort study. J Acquir Immune Defic Syndr 2002; 29:197-202.
22. Chequer P. Apresentação. Boletim Epidemiológico AIDS DST 2005; 1:3-5.
23. Mann J, Tarantola D, Netter T, editors. AIDS in the world. Cambridge/London: Harvard University Press; 1992.
24. Ayres JRCM, Calazans GJ, Saletti Filho H, França Jr. I. O conceito de vulnerabilidade e prevenção e as práticas de saúde. In: Czeresnia D, Freitas CM, organizadores. Promoção em saúde: conceitos, reflexões e tendências. Rio de Janeiro: Editora Fiocruz; 2003. p. 117-40.
25. Nascimento AMG, Barbosa CS, Medrado B. Mulheres em Camaragibe: representação social sobre a vulnerabilidade feminina em tempos de AIDS. Rev Bras Saúde Matern Infant 2005; 5:77-86.
26. Fonseca MG, Travassos C, Bastos FI, Silva NV, Szwarcwald CL. Distribuição social da AIDS no Brasil, segundo participaç ão no mercado de trabalho, ocupação e status sócio-econômico dos casos de 1987 a 1998. Cad Saúde Pública 2003; 19:1351-63.
27. Joint United Nations Programme on HIV/AIDS. Ensuring equitable access to antiretroviral treatment for women. Geneva: Joint United Nations Programme on HIV/AIDS; 2004.
28. Box TL, Olsen M, Oddone EZ, Ketz SA. Healthcare access and utilization by patients infected with human immunodeficiency virus: does gender matter? J Womens Health (Larchmt) 2003; 12:391-7.
29. Evans JS, Nims T, Cooley J, Bradley W, Jagodzinski L, Zhou S, et al. Serum levels of virus burden in early-stage human immunodeficiency virus type 1 disease in women. J Infect Dis 1997; 175:795-800.
30. Farzadegan H, Hoover DR, Astemborski J, Lyles CM, Margolick JB, Markham RB, et al. Sex differences in HIV-1 viral load and progression to AIDS. Lancet 1998; 352:1510-4.
31. Anastos K, Gange SJ, Lau B, Weiser B, Detels R, Giorgi JV, et al. Association of race and gender with HIV-1 RNA levels and immunologic progression. J Acquir Immune Defic Syndr 2000; 24:218-26.
32. Currier JS, Spino C, Grimes J, Wofsy CS, Katzenstein DA, Hughes MD, et al. Differences between women and men in adverse events and CD4+ responses in nucleoside analogue therapy for HIV infection. J Acquir Immune Defic Syndr 2000; 24:316-24.
33. Napravnik S, Poole C, Thomas JC, Eron Jr. JE. Gender difference in HIV RNA levels: a meta-analysis of published studies. J Acquir Immune Defic Syndr 2002; 31:11-9.
34. Donnelly CA, Bartley LM, Ghani AC, Le Fevre AM, Kwong GP, Cowling BJ, et al. Gender difference in HIV-1 RNA viral loads. HIV Med 2005; 6:170-8.
35. Ministério da Saúde. Recomendações para terapia anti-retroviral em adultos e adolescentes infectados pelo HIV, 2004. http://www.aids.gov.br/data (acessado em 04/Dez/2005).
36. Hader SL, Smith DK, Moore JS, Holmberg SD. HIV infection in women in the United States-status at the millennium. JAMA 2001; 285:1186-92.
37. Gebo KA, Fleishman JA, Conviser R, Reilly ED, Todd-Korthuis P, Moore RD, et al. Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multi-state sample of HIV patients in 2001. J Acquir Immune Defic Syndr 2005; 38:96-103.
38. Strathdee AS, Palepu A, Cornelisse PGA, Yip B, O'Shaughnessy MV, Montaner JSG, et al. Barriers to use of free antiretroviral therapy in injection drug users. JAMA 1998; 280:547-9.
39. Joint United Nations Programme on HIV/AIDS. Facts sheets on HIV/AIDS care and treatment. Geneva: Joint United Nations Programme on HIV/AIDS; 2004.
40. Whetten K, Reif S, Lowe K, Eldred L. Gender differences in knowledge and perceptions of HIV resources among individuals living with HIV in the Southeast. South Med J 2004; 97:342-9.